Welcome to LookChem.com Sign In|Join Free

CAS

  • or
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH is a synthetic compound that consists of a fluorenylmethoxycarbonyl (Fmoc) group, a threonine (Thr) residue, and a tris-O-acetylated N-acetylgalactosamine (GalNAc) attached to the alpha-D configuration. It is a white to off-white solid and is used in the synthesis of glycopeptides for various applications.

116783-35-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-Dgalactopyranosyl]-L-threonine

    Cas No: 116783-35-8

  • No Data

  • 1 Milligram

  • Kilogram/Month

  • NewCan Biotech Limited
  • Contact Supplier
  • L-Threonine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-a-D-galactopyranosyl]-

    Cas No: 116783-35-8

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 116783-35-8 Structure
  • Basic information

    1. Product Name: FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
    2. Synonyms: N-FMOC-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE;N-ALPHA-FMOC-O-BETA-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE;N-ALPHA-FMOC-O-(2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE;N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-O-(2-ACETAMIDO-2DEOXY-3,4,6-TRI-O-ACETYL-ALPHA-D-GALACTOPYRANOSYL)-L-THREONINE;FMOC-L-THR(TNAC4)-OH;FMOC-L-THR(ALPHA-D-GALNAC(AC)3)-OH;FMOC-THREONINE(GALNAC(AC)3-ALPHA-D)-OH;FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH
    3. CAS NO:116783-35-8
    4. Molecular Formula: C33H38N2O13
    5. Molecular Weight: 670.66
    6. EINECS: N/A
    7. Product Categories: Amino Acid;Carbohydrates & Derivatives;Fluorescent Labels & Indicators;Inhibitors;Protein Kinase Inhibitors and Activators;Glycoamino Acid
    8. Mol File: 116783-35-8.mol
  • Chemical Properties

    1. Melting Point: 178-183°C
    2. Boiling Point: 857.074 °C at 760 mmHg
    3. Flash Point: 472.142 °C
    4. Appearance: /
    5. Density: 1.38 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: -15°C
    8. Solubility: N/A
    9. PKA: 3.32±0.10(Predicted)
    10. CAS DataBase Reference: FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH(CAS DataBase Reference)
    11. NIST Chemistry Reference: FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH(116783-35-8)
    12. EPA Substance Registry System: FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH(116783-35-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 116783-35-8(Hazardous Substances Data)

116783-35-8 Usage

Uses

Used in Immunology Research:
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH is used as a building block for the synthesis of fluorescently labeled glycopeptides containing GalNAcα1-O-Ser/Thr residues. These glycopeptides serve as valuable immunology probes for the development of cancer vaccines.
Used in Pharmaceutical Industry:
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH is used as a key intermediate in the synthesis of therapeutic peptides and glycopeptides that target specific biological pathways. Its unique structure allows for the development of drugs with enhanced efficacy and selectivity.
Used in Chemical Synthesis:
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH is used as a reagent in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals. Its versatility and functional groups make it a valuable component in the development of new chemical entities.
Used in Materials Science:
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH can be used in the development of novel materials with specific properties, such as self-assembling systems, drug delivery vehicles, and biocompatible coatings. Its unique structure and functional groups enable the creation of materials with tailored properties for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 116783-35-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,7,8 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 116783-35:
(8*1)+(7*1)+(6*6)+(5*7)+(4*8)+(3*3)+(2*3)+(1*5)=138
138 % 10 = 8
So 116783-35-8 is a valid CAS Registry Number.

116783-35-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (772437)  Fmoc-Thr[GalNAc(Ac)3-α-D]-OH  97%

  • 116783-35-8

  • 772437-25MG

  • 3,749.85CNY

  • Detail
  • Aldrich

  • (772437)  Fmoc-Thr[GalNAc(Ac)3-α-D]-OH  97%

  • 116783-35-8

  • 772437-100MG

  • 8,999.64CNY

  • Detail

116783-35-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-L-threonine

1.2 Other means of identification

Product number -
Other names FMOC-THR(GALNAC(AC)3-α-D)-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:116783-35-8 SDS

116783-35-8Relevant articles and documents

Piperidine is preferred to morpholine for Fmoc cleavage in solid phase glycopeptide synthesis as exemplified by preparation of glycopeptides related to HIV gp120 and mucins

Vuljanic, Tatjana,Bergquist, Karl-Erik,Clausen, Henrik,Roy, Sarbani,Kihlberg, Jan

, p. 7983 - 8000 (1996)

Protected derivatives of the Tn antigens [Fmoc-Ser/Thr(Ac3GalNAcα)-OH, compounds 5 and 8] have been prepared by glycosylation of Fmoc-Ser/Thr- OAllyl with 3,4,6-tri-O-acetyl-2-azido-2-deoxy-D-galactopyranosyl chloride (2), followed by conversion of the azido group to an acetamide and deallylation. The derivatives 5 and 8 were used for solid phase synthesis of glycopeptides related to HIV gp120 and mucins. In these syntheses piperidine was found to give efficient Fmoc removal whereas deprotection with morpholine was slow and incomplete for some steps. In contrast to previous concerns β- elimination and epimerization of glycopeptide stereocenters was not encountered when piperidine was used for Fmoc deprotection. However, it was found that for glycopeptides which contained cysteine residues, de-O- acetylation with methanolic ammonia had to be performed before side-chain deprotection and cleavage from the solid phase.

Antifreeze glycopeptide analogues: Microwave-enhanced synthesis and functional studies

Heggemann, Carolin,Budke, Carsten,Schomburg, Benjamin,Majer, Zsuzsa,Wibrock, Marco,Koop, Thomas,Sewald, Norbert

, p. 213 - 222 (2010)

Antifreeze glycoproteins enable life at temperatures below the freezing point of physiological solutions. They usually consist of the repetitive tripeptide unit (-Ala-Ala-Thr-) with the disaccharide α-d-galactosyl-(1-3) -β-N-acetyl-d-galactosamine attached to each hydroxyl group of threonine. Monoglycosylated analogues have been synthesized from the corresponding monoglycosylated threonine building block by microwave-assisted solid phase peptide synthesis. This method allows the preparation of analogues containing sequence variations which are not accessible by other synthetic methods. As antifreeze glycoproteins consist of numerous isoforms they are difficult to obtain in pure form from natural sources. The synthetic peptides have been structurally analyzed by CD and NMR spectroscopy in proton exchange experiments revealing a structure as flexible as reported for the native peptides. Microphysical recrystallization tests show an ice structuring influence and ice growth inhibition depending on the concentration, chain length and sequence of the peptides.

Synthesis and conformational preferences of short analogues of antifreeze glycopeptides (AFGP)

Urbańczyk, Ma?gorzata,Jewgiński, Micha?,Krzciuk-Gula, Joanna,Góra, Jerzy,Latajka, Rafa?,Sewald, Norbert

, p. 1581 - 1591 (2019)

Antifreeze glycoproteins are a class of biological agents which enable living at temperatures below the freezing point of the body fluids. Antifreeze glycopeptides usually consist of repeating tripeptide unit (-Ala-Ala-Thr?-), glycosylated at the threonine side chain. However, on the microscopic level, the mechanism of action of these compounds remains unclear. As previous research has shown, antifreeze activity of antifreeze glycopeptides strongly relies on the overall conformation of the molecule as well an on the stereochemistry of amino acid residues. The desired monoglycosylated analogues with acetylated amino termini and the carboxy termini in form of N-methylamide have been synthesized. Conformational nuclear magnetic resonance (NMR) studies of the designed analogues have shown a strong influence of the stereochemistry of amino acid residues on the peptide chain stability, which could be connected to the antifreeze activity of these compounds. A better understanding of the mechanism of action of antifreeze glycopeptides would allow applying these materials, e.g., in food industry and biomedicine.

Microwave-assisted synthesis of fluorescein-labelled GalNAcα1-O-Ser/ Thr (Tn) glycopeptides as immunological probes

Lee, Dong Jun,Harris, Paul W.R.,Kowalczyk, Renata,Dunbar, P. Rod,Brimble, Margaret A.

, p. 763 - 769 (2010)

Fluorescently labelled glycopeptides containing GalNAcα1-O-Ser/Thr residues provide valuable immunological probes for the development of cancer vaccines. The microwave-assisted automated Fmoc solid-phase synthesis of a series of 5(6)-carboxyfluorescein-labelled GalNAcα1-O-Ser/Thr peptides is described. Lys(Dde)-Gly-Wang polystyrene resin was elongated using Fmoc SPPS with incorporation of several GalNAcα1-O-Ser/Thr residues. Deprotection of the Lys(Dde) then allowed attachment of the 5(6)-carboxyfluorescein label. The synthetic methodology described is flexible and suitably robust enabling the incorporation of three contiguous GalNAcα1-O-Ser residues into the peptide chain. Georg Thieme Verlag Stuttgart · New York.

Methyl esters: an alternative protecting group for the synthesis of O-glycosyl amino acid building blocks

Mayato, Carlos,Dorta, Rosa L.,Vázquez, Jesús T.

, p. 1396 - 1398 (2008)

The glycosyl amino acids α-GalNAc-Ser and α-GalNAc-Thr are fundamental building blocks for glycopeptide synthesis, Schmidt's synthesis method often being chosen for this purpose. Methyl esters used as orthogonal carboxylic acid protecting group in this pr

Chemoenzymatic synthesis of glycosylphosphatidylinositol-anchored glycopeptides

Wu, Zhimeng,Guo, Xueqing,Guo, Zhongwu

, p. 5773 - 5774 (2010)

MUC1 glycopeptide was efficiently coupled to glycosylphosphatidylinositol (GPI) derivatives by sortase A (SrtA), verifying that SrtA can accept sterically hindered glycopeptide as substrate for ligation with GPIs. This work has established a practical method for the chemoenzymatic synthesis of GPI-linked glycopeptides.

Fluorenylmethoxycarbonyl-Protected O-Glycosyl-N-methyl Amino Acids: Building Blocks for the Synthesis of Conformationally Tuned Glycopeptide Antigens

Buba, Annette E.,L?we, Holger,Kunz, Horst

, p. 5764 - 5774 (2015)

Peptide antibiotics often contain N-methylated amino acids. These N-methylamino components enhance the metabolic stability and strongly influence the conformational behavior of these peptide drugs. N-Methyl-O-glycosyl amino acids, in particular, threonine and serine derivatives, are unknown so far. Fmoc-protected N-methyl-O-glycosyl-threonine and -serine building blocks, including sialyl TN antigens, have been synthesized for the first time by converting the Fmoc-protected O-glycosyl amino acids or their tert-butyl esters into the corresponding oxazolidinones followed by reductive ring-opening. These new components are considered interesting for the construction of modified mucin glycopeptide anti-tumor vaccines with extended biological half-life. Fmoc-protected building blocks of N-methylated O-glycosyl amino acids, inaccessible so far, have been synthesized by the conversion of Fmoc-O-glycosyl amino acids into the corresponding oxazolidines followed by reductive ring-opening. These N-methyl-O-glycosyl amino acids could be used in solid-phase glycopeptide syntheses under particular conditions.

Revealing Functional Significance of Interleukin-2 Glycoproteoforms Enabled by Expressed Serine Ligation

Cao, Qi,Li, Bin,Liu, Jiazhi,Liu, Lizhen,Liu, Xinnan,Shao, Hong,Tao, Houchao,Wang, Can,Wang, Ping,Xue, Dongxiang,Ye, Farong,Yu, Biao,Zhao, Hongbo,Zhao, Jie

, (2022/01/31)

Naturally occurring interleukin-2 (IL-2) is a pleiotropic glycoprotein that regulates immune responses by controlling the differentiation and homeostasis of T cells. Non-glycosylated IL-2 has been used in clinical settings for three decades. However, the function of the O-glycan of native IL-2 remains elusive. Herein, to stress this issue, we report a highly efficient semi-synthesis of homogeneous glycosylated IL-2 with various glycoproteoforms on a multi-milligram scale. The glycopeptide fragment was prepared by chemical synthesis and then merged with recombinant fragment via a serine ligation to generate the desired glycoprotein in a single operation. Biological evaluation of the homogenous glycoprotein library reveals that the activity of IL-2 in activating individual T cell subset is glycan dependent, thus highlighting the possibility of further improving current clinical medicine.

Design and synthesis of trivalent Tn glycoconjugate polymers by nitroxide-mediated polymerization

Liu, Si-Xian,Tsai, Yun-Tzu,Lin, Yu-Tung,Li, Jia-Yue,Chang, Che-Chien

, (2019/11/26)

A new synthetic method for preparing Tn glycoconjugate polymers, containing tumor-associated carbohydrate antigens, by controlled living radical polymerization is reported. To mimic the authentic structures of Tn glycopeptide antigens and to explore the controlled living radical polymerization, three tumor-associated carbohydrate antigens (GalNAc, GalNAcα1-O-Ser, and GalNAcα1-O-Thr) were attached to a styrene-type monomer through a diethylene glycol spacer. Under nitroxide-mediated polymerization, controlled living radical polymerization proceeded to afford defined glycopeptide polymers with different Tn densities and compositions. The polydispersity index (PDI) and molecular weights were increased and conversions were decreased upon increasing the concentration of Tn glycoconjugate monomers. The resulting Tn glycoconjugate polymers were characterized by NMR and IR. The spectral data indicate that the Tn glycoconjugate moiety did attach to the polymer chain and Tn glycoconjugate density could be adjusted through the nitroxide-mediated polymerization conditions. The number of Tn units containing in the polymer chains could be estimated by NMR integration. This synthetic approach provides a new and efficient tool for constructing novel Tn glycoconjugate polymers.

Synthetic MUC1 antitumor vaccine with incorporated 2,3-sialyl-T carbohydrate antigen inducing strong immune responses with isotype specificity

Stra?burger, David,Glaffig, Markus,Stergiou, Natascha,Bialas, Sabrina,Besenius, Pol,Schmitt, Edgar,Kunz, Horst

, p. 1142 - 1146 (2018/10/21)

The endothelial glycoprotein MUC1 is known to underlie alterations in cancer by means of aberrant glycosylation accompanied by changes in morphology. The heavily shortened glycans induce a collapse of the peptide backbone and enable accessibility of the latter to immune cells, rendering it a tumor-associated antigen. Synthetic vaccines based on MUC1 tandem repeat motifs, comprising tumor-associated 2,3-sialyl-T antigen, conjugated to the immunostimulating tetanus toxoid, are reported herein. Immunization with these vaccines in a simple water/oil emulsion produced a strong immune response in mice to which stimulation with complete Freund’s adjuvant (CFA) was not superior. In both cases, high levels of IgG1 and IgG2a/b were induced in C57BL/6 mice. Additional glycosylation in the immunodominant PDTRP domain led to improved binding of the induced antisera to MCF-7 breast tumor cells, compared with that of the monoglycosylated peptide vaccine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 116783-35-8